Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Wed 139 Outcome among head trauma patients on anticoagulants or platelet inhibitors prior to trauma
Sigrid Narum, (Norway), M Kringen, O Brørs, O Stokland
Wed 140 Gender differences in the disposition of drugs
C Neta, J Silva, F Martins, A Pedroso, T Macedo, Carlso Fontes Ribeiro, (Portugal)
Wed 141 Gas mediator hydrogen as a tool for protection of Parkinson's disease
Mami Noda, (Japan), K Fujita, M Kido, T Katafuchi, Y Nakabeppu
Wed 142 Flurbiprofen pharmacokinetics in relation to CYP2C9 genotype
Da-Hee Oh, (Republic Of South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee
Wed 143 Contribution of CYP2D6*10 allele to the inter-individual variability in the pharmacokinetic of metoprolol
and its β-hydroxy metabolite in Koreans
Da-Hee Oh, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee
Wed 144 Use of confidence intervals in the fractional analysis of the interaction between non-depolarizing
neuromuscular blockers
Antonio Carlos Oliveira, (Brazil), CR Souza, WL Silva, CSM Serra
Wed 145 Effect of lamivudine-artesunate co-administration on some hematological, hepatic and renal biomarkers
in rats
Temidayo Olurishe, (Nigeria), H Kwanashie, J Anuka, H Muktar
Wed 146 Comparative study of adverse drug reactions between a public and a private specialist hospital in
Lagos, South West Nigeria
Ibrahim Oreagba, (Nigeria), I Ishola, A Akinyandenu
Wed 147 The metabolism of the novel dopamine stabiliser ACR16 (Pridopidine)is mainly mediated by CYP2D6
Georgios Panagiotidis, (Sweden), A Hellden, J Tedroff, N Waters, S Waters, L Bertilsson
Wed 148 Role of genetic factors on between-subject variability in cytarabine cytotoxicity
Sumit Parmar, (Germany), A Seeringer, K Pitterle, D Denich, F Gärtner, E Lebedeva, J Kirchheiner
Wed 149 Nephrotoxic medications in acute kidney injury: Opportunities for learning
Peysh Patel, (UK), A Sengupta, O Martin, F Razik, O Johnson
Wed 150 Early postnatal ketamine anesthesia causes persistent deficits in rhesus monkey cognition
Merle G Paule, (USA), M Li, X Zou, C Hotchkiss, JP Hanig, TA Patterson, W Slikker, C Wang
Wed 151 Linkage disequilibrium between the rapid CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9
alleles: identification of CYP2C haplotypes in healthy Nordic populations
Rasmus S Pedersen, (Denmark), C Brasch-Andersen, SC Sim, TK Bergmann, J Halling, MS Petersen,
P Weihe, A-L Börresen-Dale, VN Kristensen, K Brøsen, M Ingelman-Sundberg
Wed 152 Effects of verapamil, over materno-fetal pharmacokinetics and transplacental exchange of ivermectin,
in pregnant sheep
Ruben Perez, (Chile), C Palma, MJ Nuñez, P Urrutia, L Morales, D Vera, J Cox
Wed 153 Determining toxicological parameters of atropine/scopolamine mixture as food contaminant
L Perhariè, M Zidariè, Lovro Stanovnik, (Slovenia)
Wed 154 Parenteral alanyl-glutammine in critically ill patients: a Bayesian meta-analysis of published trials
Lorenzo Pradelli, (Italy), O Zaniolo, S Iannazzo, M Eandi
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 255